SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (28956)6/24/1999 1:55:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
I think that you are confusing the oral Targretin filing with the topical Panretin approval (which was expected in 1998). A filing of Targretin in 1999 has been the deadline for quite some time now. Last fall, it wasn't even clear if oral or topical Targretin would be filed first.